Oxidative stress markers may not be early markers of doxorubicin-induced cardiotoxicity in rabbits

By          

Experimental and Therapeutic Medicine, Vol. 2, Iss. 5, 2011-01 ,pp. : 947-950

Spandidos Publications

Access to resources Recommend Favorite

Pharmacokinetics of etoposide in cancer patients treated with high-dose etoposide and with dexrazoxane (ICRF-187) as a rescue agent

By Schroeder Patricia   Hofland Kenneth   Jensen Peter   Sehested Maxwell   Langer Seppo   Hasinoff Brian  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 1, 2004-01 ,pp. : 91-93

Springer Publishing Company

Access to resources Recommend Favorite

Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibiting the expression of peroxiredoxin III in H9c2 cells

By                            

Molecular Medicine Reports, Vol. 13, Iss. 1, 2016-01 ,pp. : 367-372

Spandidos Publications

Access to resources Recommend Favorite

Myocardial performance index and biochemical markers for early detection of doxorubicin-induced cardiotoxicity in children with acute lymphoblastic leukaemia

By Ruggiero Antonio   Rosa Gabriella   Rizzo Daniela   Leo Andrea   Maurizi Palma   Nisco Alessia   Vendittelli Francesca   Zuppi Cecilia   Mordente Alvaro   Riccardi Riccardo  

International Journal of Clinical Oncology, Vol. 18, Iss. 5, 2013-10 ,pp. : 927-933

Springer Publishing Company

Access to resources Recommend Favorite

Hydrogen sulfide attenuates doxorubicin-induced cardiotoxicity by inhibiting reactive oxygen species-activated extracellular signal-regulated kinase 1/2 in H9c2 cardiac myocytes

By                        

Molecular Medicine Reports, Vol. 12, Iss. 5, 2015-01 ,pp. : 6841-6848

Spandidos Publications

Access to resources Recommend Favorite